Solutions in development

Toward new medical indications

We leverage our first solution to extend our VisioCyt® technology to new indications. Our ambition is to address unmet medical needs, provide reliable and high-performance solutions, and improve care for the greatest number of patients.

Bladder cancer screening

VisioCyt® Screening

In development

The goal is to develop an artificial intelligence algorithm capable of detecting predictive markers of bladder cancer in urine samples, in order to create an effective screening test for this cancer in asymptomatic, high-risk patients.

Currently, no screening test exists!

Thyroid cancer diagnosis

VisioCyt® Thyroid

In development

The goal is to develop an artificial intelligence algorithm capable of detecting predictive markers of thyroid cancer from a fine-needle thyroid aspiration, in order to improve thyroid cancer detection and reduce unnecessary surgeries such as lobectomies and thyroidectomies.

Winner of the France 2030 medical imaging call for projects, in collaboration with Medipath.